Methylnaltrexone bromide
certified reference material, pharmaceutical secondary standard
Manufacturer: Supelco
CAS Number: 73232-52-7
Synonym(S): 17-(Cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxy-17-methyl-6-oxomorphinanium bromide, MNTX, Methylnaltrexonium, Mrz-2663, N-Methylnaltrexone, Naltrexone MB, Quaternary ammonium naltrexone
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 200 MG | PHR8775-200-MG | In Stock | ₹ 60,046.28 |
PHR8775 - 200 MG
In Stock
Quantity
1
Base Price: ₹ 60,046.28
GST (18%): ₹ 10,808.33
Total Price: ₹ 70,854.61
grade
certified reference materialpharmaceutical secondary standard
CofA
current certificate can be downloaded
packaging
pkg of 200 mg
application(s)
pharmaceutical
SMILES string
[Br-].C[N@+]1(CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@]2(O)CCC4=O)c35)CC6CC6
InChI
1S/C21H25NO4.BrH/c1-22(11-12-2-3-12)9-8-20-17-13-4-5-14(23)18(17)26-19(20)15(24)6-7-21(20,25)16(22)10-13;/h4-5,12,16,19,25H,2-3,6-11H2,1H3;1H/t16-,19+,20+,21-,22?;/m1./s1
InChI key
IFGIYSGOEZJNBE-KNLJMPJLSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Sigma Aldrich Fine Chemicals Biosciences Methylnaltrexone bromide United States Pharmacopeia (USP) Reference Standard | 73232-52-7 | MFCD06407831 | 100MG | Sigma Aldrich Fine Chemicals Biosciences | ₹ 1,97,361.25 | |
 | Methylnaltrexone bromide | Sigma Aldrich | ₹ 2,06,010.58 | |
 | Methylnaltrexone Peak Identification Mixture Cll | Sigma Aldrich | ₹ 1,30,159.80 |
Related Products
Description
- General description: Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
- Application: These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
- Biochem/physiol Actions: Methylnaltrexone bromide is a narcotic antagonist. It is a peripheral mu-opiod receptor antagonist that cannot cross the blood-brain barrier. It reverses many opioid side-effects without interfering with pain relief.
- Analysis Note: These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
- Other Notes: This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
STOT SE 2 Oral
Target Organs
Gastrointestinal tract
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
grade: certified reference materialpharmaceutical secondary standard
CofA: current certificate can be downloaded
packaging: pkg of 200 mg
application(s): pharmaceutical
SMILES string: [Br-].C[N@+]1(CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@]2(O)CCC4=O)c35)CC6CC6
InChI: 1S/C21H25NO4.BrH/c1-22(11-12-2-3-12)9-8-20-17-13-4-5-14(23)18(17)26-19(20)15(24)6-7-21(20,25)16(22)10-13;/h4-5,12,16,19,25H,2-3,6-11H2,1H3;1H/t16-,19+,20+,21-,22?;/m1./s1
InChI key: IFGIYSGOEZJNBE-KNLJMPJLSA-N
grade: certified reference materialpharmaceutical secondary standard
CofA: __
packaging: pkg of 50MG
application(s): pharmaceutical
SMILES string: __
InChI: 1S/C18H24N4O/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)20-22(17)2/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23)
InChI key: INMQDEMSQWWCSB-UHFFFAOYSA-N
grade: certified reference materialpharmaceutical secondary standard
CofA: __
packaging: pkg of 50MG
application(s): pharmaceutical
SMILES string: __
InChI: 1S/C17H22N4O/c1-21-12-5-4-6-13(21)10-11(9-12)18-17(22)16-14-7-2-3-8-15(14)19-20-16/h2-3,7-8,11-13H,4-6,9-10H2,1H3,(H,18,22)(H,19,20)
InChI key: GHVQAOGYNZNTIA-UHFFFAOYSA-N
